Demographics: |
Age (y) | 76.3 (0.3)***
| 81.7 ( 0.4) | 1.07 | 1.06–1.09*** |
Sex (male) | 564 [50.3]***
| 183 [39.7] | 0.83 | 0.66–1.05 |
Comorbid conditions: |
Coronary disease | 333 [29.7]1-150
| 111 [24.1] | 0.67 | 0.57–0.951-150 |
Hypertension | 325 [29.0]***
| 87 [18.9] | 0.57 | 0.43–0.76***
|
Diabetes | 223 [19.9] | 92 [20.0] | 0.99 | 0.73–1.35 |
Renal disease | 96 [8.6]1-160
| 60 [13.0] | 1.15 | 0.76–1.74 |
Chronic pulmonary disease | 219 [19.5] | 79 [17.1] | 0.71 | 0.52–0.981-150 |
Atrial fibrillation | 274 [24.4] | 110 [23.9] | 0.94 | 0.72–1.24 |
Comorbidity score index26
| 1.97 ( 0.04)***
| 2.29 ( 0.08) | 1.26 | 1.15–1.381-150 |
Medications: |
Calcium antagonists | 303 [27.0]1-150
| 100 [21.7] | 0.80 | 0.61–1.06 |
Digitalis | 833 [74.2] | 342 [74.2] | 1.03 | 0.78–1.35 |
Diuretics | 934 [83.2] | 374 [81.1] | 0.91 | 0.67–1.25 |
ACE inhibitors | 455 [40.6]***
| 123 [26.7] | 0.57 | 0.44–0.72*** |
Nitrates | 583 [52.0]1-150
| 213 [46.2] | 0.86 | 0.68–1.08 |
Antiaggregants | 134 [11.9] | 40 [8.7] | 0.71 | 0.48–1.04 |
Objective tests: |
Cognitive dysfunction | 150 [13.4]***
| 265 [57.5] | 6.51 | 3.80–11.15*** |
Serum sodium (mEq/l) | 139.8 (0.15)1-160
| 138.8 (0.31) | 0.95 | 0.90–1.01 |
Serum potassium (mEq/l) | 4.3 (0.02) | 4.3 (0.04) | 0.66 | 0.43–1.01 |
Serum creatinine (mg/dl) | 1.33 (0.03)1-160
| 1.47 (0.05) | 1.21 | 0.93–1.58 |
Systolic blood pressure (mm Hg) | 137.0 (0.76)***
| 130.0 (1.36) | 0.98 | 0.97–0.991-160
|